SILVAGNI, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 3.470
AS - Asia 3.007
EU - Europa 1.184
SA - Sud America 467
AF - Africa 275
OC - Oceania 31
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.436
Nazione #
US - Stati Uniti d'America 3.281
SG - Singapore 1.003
CN - Cina 533
IT - Italia 363
VN - Vietnam 292
BR - Brasile 270
HK - Hong Kong 221
DE - Germania 159
ID - Indonesia 156
EG - Egitto 152
GB - Regno Unito 152
IN - India 149
JP - Giappone 125
FR - Francia 108
IQ - Iraq 96
MX - Messico 90
FI - Finlandia 81
CA - Canada 76
TR - Turchia 67
EC - Ecuador 52
RU - Federazione Russa 52
PK - Pakistan 46
IR - Iran 43
PH - Filippine 43
NL - Olanda 42
ZA - Sudafrica 42
BD - Bangladesh 40
AR - Argentina 39
PL - Polonia 38
SA - Arabia Saudita 36
AU - Australia 29
CO - Colombia 29
ES - Italia 28
TW - Taiwan 28
UA - Ucraina 27
KR - Corea 26
MY - Malesia 26
PE - Perù 26
AT - Austria 22
KE - Kenya 18
SE - Svezia 17
BO - Bolivia 15
CL - Cile 14
VE - Venezuela 14
CZ - Repubblica Ceca 12
NG - Nigeria 12
BE - Belgio 11
CH - Svizzera 11
DZ - Algeria 11
MA - Marocco 11
JO - Giordania 10
HU - Ungheria 9
RO - Romania 8
IE - Irlanda 7
PS - Palestinian Territory 7
IL - Israele 6
JM - Giamaica 6
KZ - Kazakistan 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
LB - Libano 5
LT - Lituania 5
LY - Libia 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
UZ - Uzbekistan 5
AL - Albania 4
DK - Danimarca 4
ET - Etiopia 4
HN - Honduras 4
LV - Lettonia 4
MG - Madagascar 4
NP - Nepal 4
AZ - Azerbaigian 3
CR - Costa Rica 3
MM - Myanmar 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BF - Burkina Faso 2
BG - Bulgaria 2
CY - Cipro 2
KG - Kirghizistan 2
KH - Cambogia 2
LS - Lesotho 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TG - Togo 2
TN - Tunisia 2
UG - Uganda 2
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CU - Cuba 1
Totale 8.420
Città #
Singapore 612
Ashburn 549
San Jose 397
Dallas 343
Santa Clara 233
Hong Kong 198
Beijing 190
Fairfield 108
Chandler 102
Ho Chi Minh City 102
Council Bluffs 98
Tokyo 98
Los Angeles 94
Jakarta 84
Hanoi 74
Woodbridge 65
Alexandria 52
Helsinki 52
Lauterbourg 52
Houston 50
New York 48
Baghdad 45
Seattle 44
Cairo 42
Ferrara 42
Wilmington 40
Shanghai 38
Cambridge 37
Mexico City 34
Munich 34
Ann Arbor 33
Warsaw 33
London 32
São Paulo 32
Chicago 31
Montreal 28
Orem 28
Princeton 28
Atlanta 26
Buffalo 24
Frankfurt am Main 24
Hefei 24
Bologna 22
Lappeenranta 21
Brooklyn 19
Milan 19
Poplar 19
Falkenstein 18
Izmir 18
Jacksonville 18
Johannesburg 18
Nanjing 18
Da Nang 17
Denver 17
Quito 17
Toronto 17
Boston 16
Lima 16
Manchester 15
Sydney 15
Ankara 14
Chennai 14
Nairobi 14
Najaf 14
San Diego 14
Athens 13
New Delhi 13
Nuremberg 13
Padova 13
Phoenix 13
Rome 13
Haiphong 12
Kuala Lumpur 12
Amsterdam 11
City of London 11
Guayaquil 11
Lahore 11
Miami 11
Riyadh 11
Delhi 10
Hillah 10
Melbourne 10
Moscow 10
Mumbai 10
Rio de Janeiro 10
Secaucus 10
Stockholm 10
Surabaya 10
Tanta 10
Vienna 10
Budapest 9
Cuenca 9
Dhaka 9
Edinburgh 9
Elk Grove Village 9
Medan 9
Milwaukee 9
Naples 9
Tainan City 9
Bengaluru 8
Totale 5.057
Nome #
Systemic lupus erythematosus: one year in review 2023 923
Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence 336
Novel insights into the management of rheumatoid arthritis: one year in review 2022 285
The diagnosis and clinical management of the neuropsychiatric manifestations of lupus 280
Novel insights into the management of rheumatoid arthritis: one year in review 2023 259
Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study 200
Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases 192
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology 176
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus 175
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 170
Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome 169
Biological and synthetic target DMARDs in psoriatic arthritis 169
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 169
Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management 157
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis 153
Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients 152
Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis 151
Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept 147
High-grade synovitis associates with clinical markers and response to therapy in chronic inflammatory arthritis: post hoc analysis of a synovial biomarkers prospective cohort study 144
Tofacitinib restores psoriatic arthritis fibroblast-like synoviocytes function via autophagy and mitochondrial quality control modulation 144
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the Italian Society for Rheumatology 143
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis 142
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 141
Systemic lupus erythematosus: one year in review 2024 140
Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort 140
One year in review 2018: novelties in the treatment of rheumatoid arthritis 139
Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review 135
Serum Antibodies Against the Oncogenic Merkel Cell Polyomavirus Detected by an Innovative Immunological Assay With Mimotopes in Healthy Subjects 135
Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology 133
Tofacitinib improves mitochondrial function in psoriatic arthritis fibroblast-like synoviocytes via autophagy modulation 129
Cerebral Microstructure Analysis by Diffusion-Based MRI in Systemic Lupus Erythematosus: Lessons Learned and Research Directions 128
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles 127
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression 121
Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: a systematic literature review 120
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 120
Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (CPPD) disease: study using data from the international ACR/EULAR CPPD classification criteria cohort 116
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study 114
Clinical application of synovial biopsy in noninflammatory and persistent inflammatory refractory rheumatoid arthritis 108
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study 107
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 106
Neurologic Involvement in Rheumatic Diseases 98
Systemic lupus erythematosus: one year in review 2025 95
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease 94
Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology 94
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease 90
One year in review 2021: novelties in the treatment of rheumatoid arthritis 89
Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review 88
One year in review 2019: novelties in the treatment of rheumatoid arthritis 86
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 82
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology 78
Role of comorbidities on therapeutic persistence of biological agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases 76
One year in review 2020: novelties in the treatment of rheumatoid arthritis 75
SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study 70
Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology 66
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 57
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 53
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0) 45
Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort 40
Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review 39
Early antiproteinuric effect of voclosporin in patients with lupus nephritis in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience 31
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of Rheumatology 24
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in overweight and obese patients: a narrative review 18
Systemic lupus erythematosus: one year in review 2026 17
Assessing the sensitivity and the clinical impact of the 2023 ACR/EULAR classification criteria in Obstetric Antiphospholid Syndrome: findings from a multicenter Italian cohort with a long-term follow-up 12
Distinct pattern of comorbidities hinders treatment target attainment in SLE through persistent disease activity and delayed glucocorticoid tapering: longitudinal data from a multicentre cohort study 9
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study 6
Shaping rheumatoid arthritis treatment: Clinical and demographic drivers of tsDMARDs versus bDMARDs prescription post-EMA pronouncement on JAK inhibitors. Insights from the AMBI-RA study 4
Totale 8.631
Categoria #
all - tutte 37.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 253
Totale 37.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 23 17 9
2021/2022247 12 34 10 11 10 6 29 21 16 8 14 76
2022/2023245 26 32 15 18 39 17 6 21 27 4 20 20
2023/2024610 21 23 13 8 56 6 9 18 25 140 115 176
2024/20252.172 82 150 200 140 222 252 96 110 343 195 226 156
2025/20264.880 431 210 622 498 784 291 618 331 508 587 0 0
Totale 8.631